Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr 22;8(4):1417-68.
doi: 10.3390/md8041417.

Marine drugs from sponge-microbe association--a review

Affiliations
Review

Marine drugs from sponge-microbe association--a review

Tresa Remya A Thomas et al. Mar Drugs. .

Abstract

The subject of this review is the biodiversity of marine sponges and associated microbes which have been reported to produce therapeutically important compounds, along with the contextual information on their geographic distribution. Class Demospongiae and the orders Halichondrida, Poecilosclerida and Dictyoceratida are the richest sources of these compounds. Among the microbial associates, members of the bacterial phylum Actinobacteria and fungal division Ascomycota have been identified to be the dominant producers of therapeutics. Though the number of bacterial associates outnumber the fungal associates, the documented potential of fungi to produce clinically active compounds is currently more important than that of bacteria. Interestingly, production of a few identical compounds by entirely different host-microbial associations has been detected in both terrestrial and marine environments. In the Demospongiae, microbial association is highly specific and so to the production of compounds. Besides, persistent production of bioactive compounds has also been encountered in highly specific host-symbiont associations. Though spatial and temporal variations are known to have a marked effect on the quality and quantity of bioactive compounds, only a few studies have covered these dimensions. The need to augment production of these compounds through tissue culture and mariculture has also been stressed. The reviewed database of these compounds is available at www.niobioinformatics.in/drug.php.

Keywords: bioactive compounds; marine drugs; microbial symbionts; sponges.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentage distribution of compounds produced by different orders of Demospongiae in association with microbes.
Figure 2
Figure 2
Percentage distribution of compounds produced by bacterial and fungal associates in sponges.
Figure 3
Figure 3
Percentage distribution of compounds produced by associated bacteria- phylum wise.
Figure 4
Figure 4
Percentage distribution of compounds produced by associated fungi-division wise.

Similar articles

Cited by

References

    1. Hentschel U, Hopke J, Horn M, Friedrich AB, Wagner M, Hacker J, Moore BS. Molecular evidence for a uniform microbial community in sponges from different oceans. Appl Environ Microbiol. 2002;68:4431–4440. - PMC - PubMed
    1. Radjasa OK, Sabdono A, Junaidi, Zocchi E. Richness of secondary metabolite producing marine bacteria associated with sponge Haliclona sp. Int J Pharm. 2007;3:275–279.
    1. Fusetani N, Matsunaga S. Bioactive sponge peptides. Chem Rev. 1993;93:1793–1806.
    1. Lee YK, Lee JH, Lee HK. Microbial symbiosis in marine sponges. J Microbiol. 2001;39:254–264.
    1. Fieseler L, Horn M, Wagner M, Hentschel U. Discovery of the novel candidate Phylum “Poribacteria” in marine sponges. Appl Environ Microbiol. 2004;70:3724–3732. - PMC - PubMed

Publication types

Substances

LinkOut - more resources